Microlight3D at the SPIE. Conference

close permanently

Grenoble, France, September 9, 2019

Microlight3D, a specialty manufacturer of high-resolution micro-scale 2D & 3D printing systems for industrial and scientific applications, today announces that the regenerative medicine project nAngioDerm, in which it is a partner, has been selected for funding in the amount of €747K ($822K). A consortium of research agencies from several countries will distribute the European funding; among them ANR, the French National Research Agency, which will underwrite Microlight3D’s participation.